Paper41301019
Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer.
Murad V and 6 others. Cancers (Basel), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer. Papers, record 41301019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23882093 | Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. | Radiology | 2013 | https://conductscience.org/library/papers/23882093 | PubMed |
| 2 | 37592085 | [18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/37592085 | PubMed |
| 3 | 27895266 | A simple method to estimate the time-dependent receiver operating characteristic curve and the area under the curve with right censored data. | Stat Methods Med Res | 2018 | https://conductscience.org/library/papers/27895266 | PubMed |
| 4 | 35274187 | Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy. | Eur Radiol | 2022 | https://conductscience.org/library/papers/35274187 | PubMed |
| 5 | 29878949 | The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). | Dis Colon Rectum | 2018 | https://conductscience.org/library/papers/29878949 | PubMed |
| 6 | 40049747 | [18F]-FDG PET/CT in the Initial Staging of Squamous Cell Cancer of the Anal Canal: Results of a Prospective Multicenter Registry. | J Nucl Med | 2025 | https://conductscience.org/library/papers/40049747 | PubMed |
| 7 | 31482428 | Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT. | Eur J Nucl Med Mol Imaging | 2019 | https://conductscience.org/library/papers/31482428 | PubMed |
| 8 | 33509369 | Radiomics in PET/CT: Current Status and Future AI-Based Evolutions. | Semin Nucl Med | 2021 | https://conductscience.org/library/papers/33509369 | PubMed |
| 9 | 30339668 | Anal cancer in high-income countries: Increasing burden of disease. | PLoS One | 2018 | https://conductscience.org/library/papers/30339668 | PubMed |
| 10 | 32060219 | Introduction to Radiomics. | J Nucl Med | 2020 | https://conductscience.org/library/papers/32060219 | PubMed |
| 11 | 33430396 | MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33430396 | PubMed |
| 12 | 21822946 | Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. | Eur Radiol | 2011 | https://conductscience.org/library/papers/21822946 | PubMed |
| 13 | 29759568 | Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and meta-analysis. | Crit Rev Oncol Hematol | 2018 | https://conductscience.org/library/papers/29759568 | PubMed |
| 14 | 34175386 | Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. | Ann Oncol | 2021 | https://conductscience.org/library/papers/34175386 | PubMed |
| 15 | 31005205 | MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer. | Radiother Oncol | 2019 | https://conductscience.org/library/papers/31005205 | PubMed |
| 16 | 29089827 | Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI. | Korean J Radiol | 2017 | https://conductscience.org/library/papers/29089827 | PubMed |
| 17 | 23580899 | Anal cancer - a review. | Int J Health Sci (Qassim) | 2012 | https://conductscience.org/library/papers/23580899 | PubMed |
| 18 | 35020204 | Cancer statistics, 2022. | CA Cancer J Clin | 2022 | https://conductscience.org/library/papers/35020204 | PubMed |
| 19 | 37972216 | Radiomics; Contemporary Applications in the Management of Anal Cancer; A Systematic Review. | Am Surg | 2024 | https://conductscience.org/library/papers/37972216 | PubMed |
| 20 | 30694160 | Validation of A Method to Compensate Multicenter Effects Affecting CT Radiomics. | Radiology | 2019 | https://conductscience.org/library/papers/30694160 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41301019
GET https://conductscience.org/api/papers/v1/41301019/references?page=2